Taylor Monnig, the CTO of $CLSK, sold 63,713 shares of the company on 09-09-2025 for an estimated $581,062. We received data on the trade from a recent SEC filing. This was a sale of approximately 34.6% of their shares of this class of stock. Following this trade, they now own 120,337 shares of this class of $CLSK stock.
$CLSK Insider Trading Activity
$CLSK insiders have traded $CLSK stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $CLSK stock by insiders over the last 6 months:
- TAYLOR MONNIG (CTO, COO) sold 63,713 shares for an estimated $581,062
- ROGER PAUL BEYNON sold 50,000 shares for an estimated $525,285
- THOMAS LEIGH WOOD sold 44,444 shares for an estimated $357,329
- AMANDA CAVALERI has made 0 purchases and 2 sales selling 13,000 shares for an estimated $103,600.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CLSK Hedge Fund Activity
We have seen 161 institutional investors add shares of $CLSK stock to their portfolio, and 172 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ASSENAGON ASSET MANAGEMENT S.A. removed 4,336,612 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $29,142,032
- DIMENSIONAL FUND ADVISORS LP added 2,560,425 shares (+1376.3%) to their portfolio in Q2 2025, for an estimated $28,241,487
- GOLDMAN SACHS GROUP INC removed 2,369,716 shares (-39.5%) from their portfolio in Q2 2025, for an estimated $26,137,967
- ROYAL BANK OF CANADA added 1,335,824 shares (+273.2%) to their portfolio in Q2 2025, for an estimated $14,734,138
- FORT POINT CAPITAL PARTNERS LLC removed 1,249,481 shares (-43.6%) from their portfolio in Q2 2025, for an estimated $13,781,775
- VANGUARD GROUP INC added 1,137,090 shares (+4.7%) to their portfolio in Q2 2025, for an estimated $12,542,102
- MORGAN STANLEY added 954,619 shares (+10.0%) to their portfolio in Q2 2025, for an estimated $10,529,447
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CLSK Analyst Ratings
Wall Street analysts have issued reports on $CLSK in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Chardan Capital issued a "Buy" rating on 09/08/2025
- Cantor Fitzgerald issued a "Overweight" rating on 08/08/2025
- Macquarie issued a "Outperform" rating on 08/08/2025
- B. Riley Securities issued a "Buy" rating on 08/08/2025
- JP Morgan issued a "Overweight" rating on 07/28/2025
- Ladenburg Thalmann issued a "Buy" rating on 07/28/2025
To track analyst ratings and price targets for $CLSK, check out Quiver Quantitative's $CLSK forecast page.
$CLSK Price Targets
Multiple analysts have issued price targets for $CLSK recently. We have seen 6 analysts offer price targets for $CLSK in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- James McIlree from Chardan Capital set a target price of $20.0 on 09/08/2025
- Brett Knoblauch from Cantor Fitzgerald set a target price of $26.0 on 08/08/2025
- Paul Golding from Macquarie set a target price of $20.0 on 08/08/2025
- Nick Giles from B. Riley Securities set a target price of $17.0 on 08/08/2025
- Reginald Smith from JP Morgan set a target price of $15.0 on 07/28/2025
- Jon Hickman from Ladenburg Thalmann set a target price of $20.25 on 07/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
